- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bafna Pharma's board has approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of ₹3.46 Cr and a profit of ₹3.39 Cr for the quarter.
The 30th Annual General Meeting (AGM) will be held on September 19, 2025, via video conferencing. The company has set a book closure period from September 13 to September 19, 2025, with September 12, 2025, as the cut-off date for voting eligibility. Additionally, the Nomination & Remuneration Committee was reconstituted.